MC2411A1 - Nouveaux composés - Google Patents

Nouveaux composés

Info

Publication number
MC2411A1
MC2411A1 MC2329A MC2329A MC2411A1 MC 2411 A1 MC2411 A1 MC 2411A1 MC 2329 A MC2329 A MC 2329A MC 2329 A MC2329 A MC 2329A MC 2411 A1 MC2411 A1 MC 2411A1
Authority
MC
Monaco
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
MC2329A
Other languages
English (en)
French (fr)
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC2411(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MC2411A1 publication Critical patent/MC2411A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC2329A 1995-02-06 1996-02-02 Nouveaux composés MC2411A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (1)

Publication Number Publication Date
MC2411A1 true MC2411A1 (fr) 1996-12-02

Family

ID=27267578

Family Applications (1)

Application Number Title Priority Date Filing Date
MC2329A MC2411A1 (fr) 1995-02-06 1996-02-02 Nouveaux composés

Country Status (47)

Country Link
EP (3) EP0808314B1 (no)
JP (2) JP2915338B2 (no)
KR (1) KR100289885B1 (no)
CN (3) CN1090187C (no)
AR (2) AR001982A1 (no)
AT (1) AT407528B (no)
AU (2) AU701518C (no)
BE (1) BE1009112A3 (no)
BG (1) BG62967B1 (no)
BR (1) BR9600534A (no)
CA (4) CA2211522C (no)
CH (3) CH689229A5 (no)
CZ (1) CZ297171B6 (no)
DE (3) DE69621777T2 (no)
DK (2) DK11996A (no)
DZ (1) DZ1989A1 (no)
ES (1) ES2114471B1 (no)
FI (3) FI111544B (no)
FR (1) FR2730232B1 (no)
GR (1) GR1002466B (no)
HK (1) HK59397A (no)
HU (1) HUP9600255A1 (no)
IE (1) IE80500B1 (no)
IL (1) IL117035A (no)
IT (1) IT1289532B1 (no)
LU (1) LU88711A1 (no)
LV (1) LV11618B (no)
MA (1) MA23802A1 (no)
MC (1) MC2411A1 (no)
MX (1) MX9600484A (no)
MY (1) MY132529A (no)
NL (1) NL1002248C2 (no)
NO (3) NO301009B1 (no)
NZ (1) NZ280943A (no)
OA (1) OA10261A (no)
PL (1) PL189247B1 (no)
PT (1) PT101827B (no)
RO (1) RO112426B1 (no)
RU (1) RU2125052C1 (no)
SE (1) SE521084C2 (no)
SG (1) SG43787A1 (no)
SI (2) SI21923B (no)
SK (1) SK283608B6 (no)
TR (1) TR199600096A2 (no)
TW (1) TW503238B (no)
UA (1) UA49796C2 (no)
WO (1) WO1996024595A1 (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
DE69739561D1 (de) * 1996-06-13 2009-10-15 Sumitomo Chemical Co Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung
JP2000514653A (ja) * 1996-07-15 2000-11-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 立体特異的分割のためのエステラーゼのスクリーニングおよびその使用
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
AU3108097A (en) 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
ATE207065T1 (de) * 1997-08-08 2001-11-15 Aventis Pharma Gmbh Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
BR9908825A (pt) * 1998-03-16 2000-11-21 Smithkline Beecham Plc Forma cristalina de paroxetina
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
PL345885A1 (en) * 1998-08-07 2002-01-14 Smithkline Beecham Plc Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
JP2002531452A (ja) * 1998-11-30 2002-09-24 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 混合パロキセチンプロパン−２−オール溶媒和物
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2002022609A1 (fr) * 2000-09-14 2002-03-21 Asahi Glass Company, Limited Procede de production de sel de paroxetine sensiblement exempt de solvant organique
AU2002259114A1 (en) * 2002-02-22 2003-09-09 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
KR20080055990A (ko) * 2005-11-22 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 시나칼셋 ＨＣｌ의 결정형 및 이의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
US5371092A (en) * 1990-11-24 1994-12-06 Beecham Group, P.L.C. Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
CZ297171B6 (cs) 2006-09-13
CA2211522A1 (en) 1996-08-07
SI9600036A (en) 1996-10-31
IT1289532B1 (it) 1998-10-15
FI20030162A (fi) 2003-02-03
IL117035A (en) 2000-02-29
ITMI960203A0 (no) 1996-02-05
NO20015070D0 (no) 2001-10-18
SK14396A3 (en) 1996-11-06
CA2210022C (en) 2005-09-13
BG100333A (bg) 1996-08-30
RU2125052C1 (ru) 1999-01-20
TR199600096A2 (tr) 1996-08-21
NO301009B3 (no) 2003-01-06
SI21923A (sl) 2006-06-30
PL312646A1 (en) 1996-08-19
CA2168829A1 (en) 1996-08-07
ES2114471A1 (es) 1998-05-16
EP1378508A1 (en) 2004-01-07
MX9600484A (es) 1997-01-31
AR036856A2 (es) 2004-10-06
IE960104A1 (en) 1996-08-07
HUP9600255A1 (en) 1997-03-28
EP1136490B1 (en) 2004-01-07
ES2114471B1 (es) 1999-08-16
IE80500B1 (en) 1998-08-12
JPH11228571A (ja) 1999-08-24
MA23802A1 (fr) 1996-10-01
DE19603797C2 (de) 1998-11-12
BG62967B1 (bg) 2000-12-29
AU4786496A (en) 1996-08-27
CN1143643A (zh) 1997-02-26
CN1636993A (zh) 2005-07-13
CA2210023C (en) 1999-02-09
EP0808314A1 (en) 1997-11-26
PT101827A (pt) 1996-09-30
FI20030370A (fi) 2003-03-12
FR2730232A1 (fr) 1996-08-09
FR2730232B1 (fr) 1997-08-01
NL1002248A1 (nl) 1996-08-06
AU701518C (en) 2006-12-07
NZ280943A (en) 1997-01-29
DE19603797A1 (de) 1996-08-14
LV11618A (lv) 1996-12-20
CA2211522C (en) 1999-12-07
ATA21096A (de) 2000-08-15
FI960519A (fi) 1996-08-07
SI21923B (sl) 2006-12-31
PL189247B1 (pl) 2005-07-29
CH689229A5 (de) 1998-12-31
SG43787A1 (en) 1997-11-14
KR960031409A (ko) 1996-09-17
NO311519B1 (no) 2001-12-03
DK11996A (da) 1996-08-07
DZ1989A1 (fr) 2002-10-15
AU4332896A (en) 1996-08-15
AT407528B (de) 2001-04-25
CH689804A5 (de) 1999-11-30
CZ32096A3 (en) 1996-08-14
OA10261A (en) 1997-09-19
CN1090187C (zh) 2002-09-04
FI111544B (fi) 2003-08-15
DK200100223A (no) 2001-02-12
SK283608B6 (sk) 2003-10-07
BR9600534A (pt) 1997-05-13
JP2915338B2 (ja) 1999-07-05
CA2210023A1 (en) 1996-08-07
SE521084C2 (sv) 2003-09-30
UA49796C2 (uk) 2002-10-15
SE9600406D0 (sv) 1996-02-05
MX198371B (no) 2000-08-29
EP0808314B1 (en) 2002-06-12
LV11618B (en) 1997-04-20
CN1289496C (zh) 2006-12-13
NO970939L (no) 1996-08-07
SE9600406L (sv) 1996-08-07
CN1310180A (zh) 2001-08-29
TW503238B (en) 2002-09-21
KR100289885B1 (ko) 2001-05-15
PT101827B (pt) 1997-08-29
DE69621777D1 (de) 2002-07-18
LU88711A1 (fr) 1996-08-23
SI9600036B (sl) 2006-12-31
DE69631298D1 (de) 2004-02-12
NO960472L (no) 1996-08-07
CA2210022A1 (en) 1996-08-07
NO20015070L (no) 1996-08-07
HU9600255D0 (en) 1996-03-28
FI960519A0 (fi) 1996-02-05
AR001982A1 (es) 1998-01-07
CN1216055C (zh) 2005-08-24
NO970939D0 (no) 1997-02-28
EP1136490A1 (en) 2001-09-26
GR1002466B (el) 1996-11-06
DE69631298T2 (de) 2004-11-18
NL1002248C2 (nl) 1996-09-11
DE69621777T2 (de) 2003-01-02
NO960472D0 (no) 1996-02-05
JPH08245620A (ja) 1996-09-24
HK59397A (en) 1997-05-16
WO1996024595A1 (en) 1996-08-15
MY132529A (en) 2007-10-31
BE1009112A3 (fr) 1996-11-05
CH688353A5 (de) 1997-08-15
NO301009B1 (no) 1997-09-01
ITMI960203A1 (it) 1997-08-05
RO112426B1 (ro) 1997-09-30
AU701518B2 (en) 1999-01-28
IL117035A0 (en) 1996-09-12
CA2168829C (en) 1997-12-16

Similar Documents

Publication Publication Date Title
MC2411A1 (fr) Nouveaux composés
DZ1961A1 (fr) Nouveaux composés.
DZ1798A1 (fr) Nouveaux composés.
FI972970A (fi) Uusia yhdisteitä
DK1114817T3 (da) Substituerede benzylaminopiperidinforbindelser
ID16345A (id) Senyawa-senyawa heterosiklik
DE59609887D1 (de) Substituierte cyanophenyluracile
PT847391E (pt) Compostos aromaticos
BR9600251A (pt) Composto
DE69630414D1 (de) 5B4T-Kodierungsschema
DE69622104D1 (de) Spielautomat
IS4739A (is) Efnasambönd
NO974170D0 (no) Polyazacykloalkan-forbindelser
DE59610332D1 (de) Substituierte aminouracile
BR9601295A (pt) Composto
BR9608890A (pt) N-metilenotiouréias substituídas
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
DZ2446A1 (fr) Nouveaux composés
BR9611576A (pt) Composto
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
BR9609328A (pt) Bucha
DE59607732D1 (de) Substituierte benzylidencyanessigester
DE59606140D1 (de) Oberfräse
DE59607958D1 (de) Substituierte phenyluracile
ID18956A (id) Senyawa-senyawa herbisida